According to research by nova one advisor, the global cell and gene therapy market size was valued at $18.13 billion in 2023 ...
Hosted on MSN26d
Genetic tweak to drug-making cells resolves a decades-old challenge in biomanufacturingThe researchers note that these newly engineered "Warburg-null" CHO cells are also compatible with industrial cell line ... implications on the entire drug manufacturing process.
Four different technologies are used in mass flow controllers: thermal, Coriolis, differential pressure and ultrasonic.
Image: QCells. Korean-owned solar manufacturer Hanwha Qcells has issued patent infringement notice letters to several manufacturers over its solar cell manufacturing technology. According to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results